SCHEMBL4183379

SCHEMBL4183379

Cc1cccc(CCNc2nc(-c3ccc(F)c(F)c3)ncc2C(C(N)=O)c2ccncc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT6 P42226 6/20 0.38
JAK3 P52333 1/20 0.38
NR3C2 P08235 1/20 0.38
CSNK2A2 P19784 2/20 0.36
CSNK2A1 P68400 2/20 0.36
POLB P06746 1/20 0.35
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
VNN1 O95497 1/20 0.34
RPS6KB1 P23443 1/20 0.34
AKT1 P31749 1/20 0.34
GBA1 P04062 1/20 0.34
USP1 O94782 1/20 0.34
WDR48 Q8TAF3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183068 0.92 PTAFR (0.39) STAT6JAK3NR3C2CSNK2A2CSNK2A1
SCHEMBL4183372 0.88 STAT6 (0.38) STAT6JAK3NR3C2POLBTSHR
SCHEMBL4185586 0.84 GBA1 (0.39) JAK3CSNK2A2CSNK2A1GBA1
SCHEMBL4185958 0.81 STAT6 (0.39) STAT6JAK3NR3C2POLBTSHR
SCHEMBL13743367 0.80 FLT3 (0.45) STAT6JAK3SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL4184004 0.76 GBA1 (0.44) JAK3SMN1; SMN2VNN1GBA1
SCHEMBL4183377 0.76 POLB (0.35) STAT6JAK3CSNK2A2CSNK2A1POLB
SCHEMBL13743392 0.76 LMNA (0.44) JAK3POLBTSHRCYP1A2CYP3A4
SCHEMBL13743496 0.74 JAK3 (0.43) STAT6JAK3SMN1; SMN2ALDH1A1F2
SCHEMBL4178991 0.74 NAMPT (0.40) JAK3SMN1; SMN2GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods MYLK, MYH2, MYH10 STAT6 2728/4885JAK3 2944/4885NR3C2 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.